TASSONE, PIERFRANCESCO
TASSONE, PIERFRANCESCO
Dipartimento di Medicina sperimentale e clinica
277 POSTER An interleukin-6 antagonist modified for bone targeting preserves anti-myeloma biological activity
2006-01-01 Casadonte, F.; Terracciano, R.; Gaspari, M.; Arcone, R.; Malara, N.; Paolino, D.; Fresta, M.; Tassone, P.; Venuta, S.; Savino, R.
[Extended subcutaneous mastectomy. A new type of operation in non-destructive surgery of breast neoplasms]. FT La mastectomia sottocutanea allargata. Un nuovo tipo d'intervento nella chirurgia non demolitiva della neoplasia mammaria.
1982-01-01 Montruccoli, G C; Lauro, R; Tassone, P
[Magnesium salts in the treatment of ventricular tachycardia]. FT I sali di magnesio nel trattamento della tachicardia ventricolare.
1987-01-01 Perticone, F; Pintaudi, C; Cuda, G; Spadea, F; Tassone, P; Mattioli, P L
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells in vitro
2014-01-01 Leotta, M; Biamonte, L; Raimondi, L; Ronchetti, D; Martino, Mt; Botta, C; Leone, E; Pitari, Mr; Neri, A; Giordano, A; Tagliaferri, P; Amodio, N; Tassone, P
A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells
2016-01-01 Gulla', A; Di Martino, Mt; Gallo Cantafio, Me; Morelli, E; Amodio, N; Botta, C; Pitari, Mr; Lio, Sg; Stamato, Ma; Hideshima, T; Munshi, Nc; Anderson, Kc; Tagliaferri, P; Tassone, P; Britti, Domenico
A 5 ' regulatory sequence containing two Ets motifs controls the expression of the Wiskott-Aldrich syndrome protein (WASP) gene in human hematopoietic cells
1998-01-01 Petrella, A; Doti, I; Giarrusso, Pc; Vitale, D; Cuomo, C; Tassone, P; Franco, B; Ballabio, A; Venuta, S; Morrone, G; Bond, H; Agosti, V
A clinically relevant SCID-hu in vivo model of human multiple myeloma
2005-01-01 Tassone, P; Neri, P; Carrasco, Dr; Burger, R; Goldmacher, Vs; Fram, R; Munshi, V; Shammas, Ma; Catley, L; Jacob, Gs; Venuta, S; Anderson, Kc; Munshi, Nc
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias
2015-01-01 Lionetti, M; Barbieri, M; Todoerti, K; Agnelli, L; Fabris, S; Tonon, G; Segalla, S; Cifola, I; Pinatel, E; Tassone, P; Musto, P; Baldini, L; Neri, A
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine.
2019-01-01 Catalano, R; Rocca, Roberta; Juli, Giada; Costa, Giosuè; Maruca, A; Artese, A; Caracciolo, D; Tagliaferri, P; Alcaro, S; Tassone, P; Amodio, N.
A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival
2016-01-01 Botta, C; Di Martino, Mt; Ciliberto, D; Cucè, M; Correale, P; Tagliaferri, P; Tassone, P; Rossi, M
A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma
2009-01-01 Fulciniti, M; Hideshima, T; VERMOT-DESROCHES, C; Pozzi, S; Nanjappa, P; Shen, Z; Patel, N; Smith, Es; Wang, W; Prabhala, R; Tai, Yt; Tassone, P; Anderson, Kc; Munshi, Nc
A MIR17HG-derived Long Noncoding RNA Provides an Essential Chromatin Scaffold for Protein Interaction and Myeloma Growth
2022-01-01 Morelli, Eugenio; Fulciniti, Mariateresa; Samur, Mehmet K; Ribeiro, Caroline; Wert-Lamas, Leon; Henninger, Jonathan E; Gulla, Annamaria; Aktas Samur, Anil; Todoerti, Katia; Talluri, Srikanth; Park, Woojun D; Federico, Cinzia; Scionti, Francesca; Amodio, Nicola; Bianchi, Giada; Johnstone, Megan; Liu, Na; Gramegna, Doriana; Maisano, Domenico; Russo, Nicola A; Lin, Charles Y; Tai, Yu-Tzu; Neri, Antonino; Chauhan, Dharminder; Hideshima, Teru; Shammas, Masood A; Tassone, Pierfrancesco; Gryaznov, Sergei; Young, Richard; Anderson, Kenneth C; Novina, Carl D; Loda, Massimo; Munshi, Nikhil C
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells
2022-01-01 Riillo, Caterina; Caracciolo, Daniele; Grillone, Katia; Polerà, Nicoletta; Tuccillo, Franca Maria; Bonelli, Patrizia; Juli, Giada; Ascrizzi, Serena; Scionti, Francesca; Arbitrio, Mariamena; Lopreiato, Mariangela; Siciliano, Maria Anna; Sestito, Simona; Talarico, Gabriella; Galea, Eulalia; Galati, Maria Concetta; Pensabene, Licia; Loprete, Giovanni; Rossi, Marco; Ballerini, Andrea; Gentile, Massimo; Britti, Domenico; Di Martino, Maria Teresa; Tagliaferri, Pierosandro; Tassone, Pierfrancesco
A novel monoclonal antibody recognizing human thymocytes and B-cell chronic lymphocytic leukemia cells
1994-01-01 Tassone, P; Bonelli, P; Tuccillo, F; Turco, Mc; Morrone, G; Cecco, L; Cerra, M; Venuta, S; Bond, H
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells
2014-01-01 Leotta, Marzia; Biamonte, Lavinia; Raimondi, Lavinia; Ronchetti, Domenica; Di Martino, Maria Teresa; Botta, Cirino; Leone, Emanuela; Pitari, Maria Rita; Neri, Antonino; Giordano, Antonio; Tagliaferri, Pierosandro; Tassone, Pierfrancesco; Amodio, Nicola
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells
2014-01-01 Leotta, M; Biamonte, L; Raimondi, L; Ronchetti, D; Di Martino, Mt; Botta, C; Leone, E; Pitari, Mr; Neri, A; Giordano, A; Tagliaferri, P; Tassone, P; Amodio, N
A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling
2011-01-01 Di Martino Maria, T.; Arbitrio, Mariamena; Guzzi Pietro, H.; Leone, Emanuela; Baudi, Francesco; Piro, Eugenio; Prantera, Tullia; Cucinotto, Iole; Calimeri, Teresa; Rossi, Marco; Veltri, Pierangelo; Cannataro, Mario; Tagliaferri, Pierosandro; Tassone, Pierfrancesco
A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer.
2014-01-01 Kang, Yk; Rha, Sy; Tassone, P; Barriuso, J; Yu, R; Szado, T; Garg, A; Bang, Yj.
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics
2022-01-01 Staropoli, N.; Arbitrio, M.; Salvino, A.; Scionti, F.; Ciliberto, D.; Ingargiola, R.; Labanca, C.; Agapito, G.; Iuliano, E.; Barbieri, V.; Cuce, M.; Zuccala, V.; Cannataro, M.; Tassone, P.; Tagliaferri, P.
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer
2023-01-01 Riillo, Caterina; Polerà, Nicoletta; Di Martino, Maria Teresa; Juli, Giada; Hokanson, Craig A; Odineca, Tatjana; Signorelli, Stefania; Grillone, Katia; Ascrizzi, Serena; Mancuso, Antonia; Staropoli, Nicoletta; Caparello, Basilio; Cerra, Maria; Nisticò, Giuseppe; Tagliaferri, Pierosandro; Crea, Roberto; Caracciolo, Daniele; Tassone, Pierfrancesco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 277 POSTER An interleukin-6 antagonist modified for bone targeting preserves anti-myeloma biological activity | 1-gen-2006 | Casadonte, F.; Terracciano, R.; Gaspari, M.; Arcone, R.; Malara, N.; Paolino, D.; Fresta, M.; Tassone, P.; Venuta, S.; Savino, R. | |
| [Extended subcutaneous mastectomy. A new type of operation in non-destructive surgery of breast neoplasms]. FT La mastectomia sottocutanea allargata. Un nuovo tipo d'intervento nella chirurgia non demolitiva della neoplasia mammaria. | 1-gen-1982 | Montruccoli, G C; Lauro, R; Tassone, P | |
| [Magnesium salts in the treatment of ventricular tachycardia]. FT I sali di magnesio nel trattamento della tachicardia ventricolare. | 1-gen-1987 | Perticone, F; Pintaudi, C; Cuda, G; Spadea, F; Tassone, P; Mattioli, P L | |
| A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells in vitro | 1-gen-2014 | Leotta, M; Biamonte, L; Raimondi, L; Ronchetti, D; Martino, Mt; Botta, C; Leone, E; Pitari, Mr; Neri, A; Giordano, A; Tagliaferri, P; Amodio, N; Tassone, P | |
| A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells | 1-gen-2016 | Gulla', A; Di Martino, Mt; Gallo Cantafio, Me; Morelli, E; Amodio, N; Botta, C; Pitari, Mr; Lio, Sg; Stamato, Ma; Hideshima, T; Munshi, Nc; Anderson, Kc; Tagliaferri, P; Tassone, P; Britti, Domenico | |
| A 5 ' regulatory sequence containing two Ets motifs controls the expression of the Wiskott-Aldrich syndrome protein (WASP) gene in human hematopoietic cells | 1-gen-1998 | Petrella, A; Doti, I; Giarrusso, Pc; Vitale, D; Cuomo, C; Tassone, P; Franco, B; Ballabio, A; Venuta, S; Morrone, G; Bond, H; Agosti, V | |
| A clinically relevant SCID-hu in vivo model of human multiple myeloma | 1-gen-2005 | Tassone, P; Neri, P; Carrasco, Dr; Burger, R; Goldmacher, Vs; Fram, R; Munshi, V; Shammas, Ma; Catley, L; Jacob, Gs; Venuta, S; Anderson, Kc; Munshi, Nc | |
| A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias | 1-gen-2015 | Lionetti, M; Barbieri, M; Todoerti, K; Agnelli, L; Fabris, S; Tonon, G; Segalla, S; Cifola, I; Pinatel, E; Tassone, P; Musto, P; Baldini, L; Neri, A | |
| A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine. | 1-gen-2019 | Catalano, R; Rocca, Roberta; Juli, Giada; Costa, Giosuè; Maruca, A; Artese, A; Caracciolo, D; Tagliaferri, P; Alcaro, S; Tassone, P; Amodio, N. | |
| A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival | 1-gen-2016 | Botta, C; Di Martino, Mt; Ciliberto, D; Cucè, M; Correale, P; Tagliaferri, P; Tassone, P; Rossi, M | |
| A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma | 1-gen-2009 | Fulciniti, M; Hideshima, T; VERMOT-DESROCHES, C; Pozzi, S; Nanjappa, P; Shen, Z; Patel, N; Smith, Es; Wang, W; Prabhala, R; Tai, Yt; Tassone, P; Anderson, Kc; Munshi, Nc | |
| A MIR17HG-derived Long Noncoding RNA Provides an Essential Chromatin Scaffold for Protein Interaction and Myeloma Growth | 1-gen-2022 | Morelli, Eugenio; Fulciniti, Mariateresa; Samur, Mehmet K; Ribeiro, Caroline; Wert-Lamas, Leon; Henninger, Jonathan E; Gulla, Annamaria; Aktas Samur, Anil; Todoerti, Katia; Talluri, Srikanth; Park, Woojun D; Federico, Cinzia; Scionti, Francesca; Amodio, Nicola; Bianchi, Giada; Johnstone, Megan; Liu, Na; Gramegna, Doriana; Maisano, Domenico; Russo, Nicola A; Lin, Charles Y; Tai, Yu-Tzu; Neri, Antonino; Chauhan, Dharminder; Hideshima, Teru; Shammas, Masood A; Tassone, Pierfrancesco; Gryaznov, Sergei; Young, Richard; Anderson, Kenneth C; Novina, Carl D; Loda, Massimo; Munshi, Nikhil C | |
| A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells | 1-gen-2022 | Riillo, Caterina; Caracciolo, Daniele; Grillone, Katia; Polerà, Nicoletta; Tuccillo, Franca Maria; Bonelli, Patrizia; Juli, Giada; Ascrizzi, Serena; Scionti, Francesca; Arbitrio, Mariamena; Lopreiato, Mariangela; Siciliano, Maria Anna; Sestito, Simona; Talarico, Gabriella; Galea, Eulalia; Galati, Maria Concetta; Pensabene, Licia; Loprete, Giovanni; Rossi, Marco; Ballerini, Andrea; Gentile, Massimo; Britti, Domenico; Di Martino, Maria Teresa; Tagliaferri, Pierosandro; Tassone, Pierfrancesco | |
| A novel monoclonal antibody recognizing human thymocytes and B-cell chronic lymphocytic leukemia cells | 1-gen-1994 | Tassone, P; Bonelli, P; Tuccillo, F; Turco, Mc; Morrone, G; Cecco, L; Cerra, M; Venuta, S; Bond, H | |
| A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells | 1-gen-2014 | Leotta, Marzia; Biamonte, Lavinia; Raimondi, Lavinia; Ronchetti, Domenica; Di Martino, Maria Teresa; Botta, Cirino; Leone, Emanuela; Pitari, Maria Rita; Neri, Antonino; Giordano, Antonio; Tagliaferri, Pierosandro; Tassone, Pierfrancesco; Amodio, Nicola | |
| A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells | 1-gen-2014 | Leotta, M; Biamonte, L; Raimondi, L; Ronchetti, D; Di Martino, Mt; Botta, C; Leone, E; Pitari, Mr; Neri, A; Giordano, A; Tagliaferri, P; Tassone, P; Amodio, N | |
| A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling | 1-gen-2011 | Di Martino Maria, T.; Arbitrio, Mariamena; Guzzi Pietro, H.; Leone, Emanuela; Baudi, Francesco; Piro, Eugenio; Prantera, Tullia; Cucinotto, Iole; Calimeri, Teresa; Rossi, Marco; Veltri, Pierangelo; Cannataro, Mario; Tagliaferri, Pierosandro; Tassone, Pierfrancesco | |
| A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer. | 1-gen-2014 | Kang, Yk; Rha, Sy; Tassone, P; Barriuso, J; Yu, R; Szado, T; Garg, A; Bang, Yj. | |
| A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics | 1-gen-2022 | Staropoli, N.; Arbitrio, M.; Salvino, A.; Scionti, F.; Ciliberto, D.; Ingargiola, R.; Labanca, C.; Agapito, G.; Iuliano, E.; Barbieri, V.; Cuce, M.; Zuccala, V.; Cannataro, M.; Tassone, P.; Tagliaferri, P. | |
| A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer | 1-gen-2023 | Riillo, Caterina; Polerà, Nicoletta; Di Martino, Maria Teresa; Juli, Giada; Hokanson, Craig A; Odineca, Tatjana; Signorelli, Stefania; Grillone, Katia; Ascrizzi, Serena; Mancuso, Antonia; Staropoli, Nicoletta; Caparello, Basilio; Cerra, Maria; Nisticò, Giuseppe; Tagliaferri, Pierosandro; Crea, Roberto; Caracciolo, Daniele; Tassone, Pierfrancesco |